Cancer survival corrected for heterogeneity in patient withdrawal.
about
Survival of patients with metastatic breast cancer: twenty-year data from two SEER registriesCancer Patients' Survival: Standard Calculation Methods And Some Considerations Regarding Their Interpretation: POPULACIJSKO PREŽIVETJE BOLNIKOV Z RAKOM: UPORABA RAZLIČNIH PRISTOPOV IN PROBLEMI INTERPRETACIJE REZULTATOVEstimating and modeling the cure fraction in population-based cancer survival analysisUsing relative survival measures for cross-sectional and longitudinal benchmarks of countries, states, and districts: the BenchRelSurv- and BenchRelSurvPlot-macros.Secular trends in colon and rectal cancer relative survival.Cancer net survival on registry data: use of the new unbiased Pohar-Perme estimator and magnitude of the bias with the classical methods.Role of BRCA2 mutation status on overall survival among breast cancer patients from SardiniaCalculating age-adjusted cancer survival estimates when age-specific data are sparse: an empirical evaluation of various methods.Doubly robust estimator for net survival rate in analyses of cancer registry data.Cancer survival analysis in Hamburg 1995-2003: assessing the data quality within a population-based registry.Clinicopathological diagnosis and differential criteria of thrombocythemias in various myeloproliferative disorders by histopathology, histochemistry and immunostaining from bone marrow biopsies.German cancer statistics 2004.Long-term survival of cancer patients compared to heart failure and stroke: a systematic review.Female breast cancer survival in Qidong, China, 1972-2011: a population-based studyEstimating relative survival among people registered with cancer in England and Wales.Establishing a follow-up of the Swiss MONICA participants (1984-1993): record linkage with census and mortality data.Geographical variation in cancer patient survival in Finland: chance, confounding, or effect of treatment?Education, survival and avoidable deaths in cancer patients in FinlandConditional survival of cancer patients: an Australian perspective.Cancer survival in Cali, Colombia: A population-based study, 1995-2004.Interpreting trends in cancer patient survival.Relative survival: a useful tool to assess generalisability in longitudinal studies of health in older persons.REGSTATTOOLS: freeware statistical tools for the analysis of disease population databases used in health and social studies.Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project.Correlation between mutational status and survival and second cancer risk assessment in patients with gastrointestinal stromal tumors: a population-based study.Long term relative survival after surgery for abdominal aortic aneurysm in western Australia: population based study.Standard errors of non-standardised and age-standardised relative survival of cancer patients.Comparison of different approaches to estimating age standardized net survival.Improved prognosis of breast cancer since 1970 in south-eastern Netherlands.An update of the Mayo Clinic cohort of patients with adult primary central nervous system vasculitis: description of 163 patients.Analysing population-based cancer survival - settling the controversies.Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study.Bone Scan Index: a prognostic imaging biomarker for high-risk prostate cancer patients receiving primary hormonal therapy.Cancer survival in Kampala, UgandaPopulation-based monitoring of cancer patient survival in situations with imperfect completeness of cancer registrationInfluence of stage at diagnosis on survival differences for rectal cancer in three European populationsLoss-adjusted survival of cervix cancer in Khon Kaen, Northeast Thailand.Persistent excess mortality from lung cancer in patients with stage I non-small-cell lung cancer, disease-free after 5 years.Up-to-date estimates of long-term cancer survival in England and Wales.Combining cohort and period methods for retrospective time trend analyses of long-term cancer patient survival rates
P2860
Q24806397-BD75E775-EBAC-4E9C-BB3C-381F47F44B32Q26747151-6A320F86-81EE-42A4-BE7A-C7E5CEE0259CQ29041007-6802617A-DAE4-4FEB-AB88-2522766E89F1Q30537799-E7D6497A-D785-485E-953E-006F6FB4AC0CQ30558513-B4B53739-565B-4003-9387-9ADF6F5BD40BQ30563963-8F78E83F-03EE-4732-A868-7E5BBBEF0F4DQ30858718-F1444733-BC28-445C-B704-7BFE6D8557DEQ31030500-F5E56FA1-4DBE-4B35-80F3-DD902116E3BDQ31118875-A67F8AB8-BFE5-4938-92EA-818A9EF7ACEEQ31161889-DD861D88-AAF0-46C5-ADC9-E5E20BAEB672Q33328618-1E20E8CE-6490-47D6-B47E-2BF3116039A9Q33533451-7D0B7908-B7C6-4A9D-92FC-5F8A5D076987Q33543986-6E65953B-1FF0-4E08-B078-4B0C2686302BQ33593703-62DDB457-78C6-42D9-9BC7-274D2729BF86Q33688742-E9124E94-34C5-499E-8006-D7E7F9ABA8B7Q33698565-739C3CFA-59E8-4F83-8F5F-87D7100DDF99Q33705068-D9A0AE3C-1F62-42A4-87B3-A4BD200DD0D6Q34250167-13D533A6-4A72-4AA9-BF00-62A939F5DDD5Q34435964-F783CAAF-F687-4008-873E-357D0B081748Q34479108-52F67131-1025-4432-9F58-CD8B903498D4Q34553245-EB18B07D-951D-4B27-B408-2E2D40C53A68Q34576419-B956C0C0-2765-4BFA-A1DB-A21B94B9BEECQ34622926-3F60CA48-74F8-45F5-83C6-70E51BD19554Q34890475-32A77B9C-E6F9-468B-9EBF-E97A0AD0544EQ35108718-AF5A52C0-B496-449F-A1F5-13E1255103F6Q35324356-5ED8E03F-C81B-4E22-B6E2-CEB552B38D80Q35739547-B81E8DD7-8347-47D7-92B8-FB922D5451D8Q35746703-D13781F5-3A3B-4055-8AA2-5AC96875D2F0Q36080002-7D401864-CFD6-475B-B006-B288EA71FFB9Q36193953-37350E4C-2009-499C-B8E4-654E538F495DQ36212210-DF67D295-D011-40CA-8F28-665C90E54F2CQ36579101-2C0B0DB1-33D0-473E-B573-A7F3FD897378Q36604585-62F444E8-925B-4C74-ACB6-7B85F087C776Q36616861-C37BB597-4523-4F8F-AD01-238083E817B4Q36616982-C9CE9F24-C4B4-417A-AD68-B3044FA3A888Q36619754-DD4CE09C-52FC-48C0-915D-B848751B9D00Q36625983-39747FD3-BC9F-4FFA-BB02-82D61FF16076Q36648979-9885A805-6A1B-448A-94EC-90BBF45278C2Q36670767-75222A68-FF91-4E0C-AA3C-58AF5F4D4233Q36671073-87306DA5-B741-490E-938D-92BD76DDA74E
P2860
Cancer survival corrected for heterogeneity in patient withdrawal.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年学术文章
@wuu
1982年学术文章
@zh
1982年学术文章
@zh-cn
1982年学术文章
@zh-hans
1982年学术文章
@zh-my
1982年学术文章
@zh-sg
1982年學術文章
@yue
1982年學術文章
@zh-hant
name
Cancer survival corrected for heterogeneity in patient withdrawal.
@en
Cancer survival corrected for heterogeneity in patient withdrawal.
@nl
type
label
Cancer survival corrected for heterogeneity in patient withdrawal.
@en
Cancer survival corrected for heterogeneity in patient withdrawal.
@nl
prefLabel
Cancer survival corrected for heterogeneity in patient withdrawal.
@en
Cancer survival corrected for heterogeneity in patient withdrawal.
@nl
P356
P1433
P1476
Cancer survival corrected for heterogeneity in patient withdrawal.
@en
P2093
Hakulinen T
P304
P356
10.2307/2529873
P407
P577
1982-12-01T00:00:00Z